| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥10.4B | ¥12.3B | -14.9% |
| Operating Income | ¥-0.3B | ¥0.7B | -31.4% |
| Ordinary Income | ¥-0.3B | ¥0.7B | -30.7% |
| Net Income | ¥-0.5B | ¥0.3B | -48.7% |
| ROE | -3.4% | 2.1% | - |
FY2025 Q1 results show revenue of 10.4B yen (YoY -14.9%), operating income of -0.3B yen (deteriorating from +0.7B yen in prior year), ordinary income of -0.3B yen (YoY -30.7%), and net loss of -0.5B yen (deteriorating from +0.3B yen profit in prior year, YoY -48.7%). The company shifted to losses across all profit levels, with basic EPS falling to -15.93 yen from +10.21 yen in the prior year. This represents the first period of operating losses in available data. The company announced a tender offer by Illgurm Corporation that is expected to result in delisting, and accordingly has not disclosed FY2026 earnings guidance or dividend forecasts.
Revenue declined 14.9% YoY to 10.4B yen, reflecting challenges in the business foundation. The revenue contraction stems from reduced business volume, though specific segment or product-line drivers are not disclosed in the available data. The company operates with a lean cost structure but faces pressure from fixed cost burdens relative to the declining revenue base.
Operating income deteriorated significantly to -0.3B yen from +0.7B yen in the prior year, representing a 31.4% decline in absolute terms and a shift to losses. Operating margin contracted to -2.7%, down from positive territory in the prior year. This deterioration reflects the impact of revenue decline combined with operating costs that did not adjust proportionately. Personnel expenses of 319M yen and executive compensation of 80M yen represent substantial fixed costs that weigh on profitability when revenue contracts.
Ordinary income of -0.3B yen closely tracked operating income, indicating minimal non-operating income or expense impact. The gap between ordinary income and pre-tax loss widened to 370M yen due to extraordinary losses of 360M yen, primarily from disposal of fixed assets totaling 100M yen. These non-recurring charges significantly impacted net income, which fell to -0.5B yen. The effective tax benefit of approximately 200M yen partially offset the pre-tax loss of -0.6B yen. Income tax expense recorded as -0.2B yen suggests tax benefits recognized against losses.
Intangible assets declined sharply by 66.2% from 360M yen to 120M yen, indicating material write-downs, amortization, or disposals during the period. This asset structure change warrants attention as it may signal strategic shifts or impairment recognition.
The company exhibits a revenue down/profit down pattern, with both top-line contraction and magnified bottom-line deterioration driven by operating deleverage and one-time charges.
[Profitability] ROE of -3.4% deteriorated significantly from positive territory in the prior year, driven by net loss generation. Operating margin of -2.7% reflects structural challenges in the cost base relative to current revenue levels. EBIT margin similarly stands at -2.7%, confirming negative operating profitability before financial items. The company's profitability metrics show room for improvement through either revenue recovery or cost structure optimization. [Cash Quality] Cash and deposits of 11.7B yen provide substantial liquidity coverage, representing 17.5x coverage of short-term liabilities. This strong cash position buffers against near-term financial stress despite operational losses. [Investment Efficiency] Total asset turnover of 0.721x indicates assets generate 0.72 yen of revenue per yen of assets, reflecting the impact of revenue contraction on asset productivity. [Financial Health] Equity ratio of 95.4% demonstrates an extremely conservative capital structure with minimal financial leverage. Current ratio exceeds 2,000%, indicating exceptional short-term liquidity. The absence of meaningful debt results in negligible debt-to-equity ratios and minimal financial risk from leverage.
Operating cash flow of -0.2B yen represents 0.40x of net income, falling below the 0.8x threshold and indicating challenges in converting accounting profits to cash. The cash flow subtotal before working capital changes of 0.2B yen reflects operating earnings plus depreciation of 0.3B yen, but this was offset by working capital movements including a 0.4B yen change in receivables and income taxes paid of -0.2B yen. Trade receivables declined from 1.8B yen to 1.4B yen, contributing positively to working capital efficiency. Investing cash flow of 0.1B yen was positive despite capital expenditures of -0.0B yen, suggesting minimal investment activity or possible proceeds from asset disposals. The capex-to-depreciation ratio of 0.03 indicates investment spending well below replacement levels, raising concerns about future growth capacity. Free cash flow of -0.1B yen reflects the combination of negative operating cash flow and minimal investing activity. Financing cash flow of 0.0B yen with share repurchases of -0.0B yen indicates limited capital allocation activity during the period. Despite negative free cash flow, the substantial cash position of 11.7B yen provides adequate liquidity to absorb near-term cash consumption.
Ordinary income of -0.3B yen closely aligned with operating income of -0.3B yen, indicating minimal non-operating impact on core profitability. Non-operating income and expenses both registered at approximately 0.0B yen, with interest income of 0.0B yen and negligible other non-operating items. This indicates the company generates limited financial income from its substantial cash holdings. Extraordinary losses of 0.4B yen materialized from asset disposals and represented 26.6% of the absolute value of net income, qualifying as material non-recurring factors. The disposal loss of 0.1B yen specifically relates to fixed asset write-offs. The sharp 66.2% decline in intangible assets from 360M yen to 120M yen may reflect additional impairment or amortization beyond ordinary levels. Operating cash flow of -0.2B yen fell short of net loss levels, indicating that working capital movements and other adjustments consumed cash beyond the accounting loss. The operating CF to net income ratio of 0.40 signals earnings quality concerns, as cash generation lags reported profitability. The combination of extraordinary charges and weak cash conversion suggests that underlying earnings power requires careful assessment beyond headline figures.
Revenue contraction risk remains elevated as the 14.9% YoY decline indicates loss of business volume or market share. Without disclosed segment information or forward guidance, visibility into revenue stabilization or recovery remains limited. The tender offer and planned delisting introduce uncertainty around business strategy and resource allocation under new ownership, potentially affecting operational continuity and growth investments.
Operating leverage risk has materialized with the shift to negative operating margins of -2.7%. Fixed costs including personnel expenses of 319M yen and executive compensation of 80M yen create earnings volatility when revenue fluctuates. The cost structure requires optimization to restore profitability at current or lower revenue levels, and failure to adjust the cost base could extend losses.
Cash consumption risk emerges from negative operating cash flow of -0.2B yen and negative free cash flow of -0.1B yen. While current cash holdings of 11.7B yen provide substantial runway, sustained cash consumption would eventually pressure liquidity. The capex-to-depreciation ratio of 0.03 indicates investment spending well below replacement levels, which may constrain future competitiveness but also reflects capital allocation caution during this uncertain period.
[Industry Position] (Reference - Proprietary Analysis)
The company's operating margin of -2.7% represents underperformance relative to typical industry profitability standards. Revenue contraction of 14.9% YoY significantly exceeds normal industry volatility, indicating company-specific challenges rather than sector-wide trends. The equity ratio of 95.4% positions the company as exceptionally conservative relative to industry capital structures, where moderate leverage is common. This reflects minimal financial risk but also underutilization of capital structure optimization for returns. ROE of -3.4% falls well below median industry returns due to the current period losses, though the strong balance sheet provides financial stability during this performance trough. The substantial cash holdings equivalent to over 100% of annual revenue distinguish the company as highly liquid compared to sector peers, providing strategic flexibility despite operational challenges. Investment intensity as measured by the capex-to-depreciation ratio of 0.03 trails industry norms, suggesting deferred growth investments that may impact competitive positioning.
The company faces a critical inflection point with the announced tender offer by Illgurm Corporation and planned delisting, which represents a fundamental change in corporate structure and governance. This transaction introduces uncertainty around future business strategy, capital allocation, and operational priorities under new ownership. The combination of strong financial health with weak operational performance creates a turnaround scenario where substantial cash reserves of 11.7B yen and minimal financial leverage provide resources to address revenue and profitability challenges. The asset-light structure with 95.4% equity ratio offers financial flexibility for strategic redirection.
Earnings quality concerns emerge from the operating CF to net income ratio of 0.40, indicating that cash generation significantly lags reported results. The extraordinary losses of 360M yen and sharp 66.2% decline in intangible assets signal one-time charges and asset structure changes that distort underlying performance trends. Adjusting for these non-recurring items suggests core operations may be less impaired than headline figures indicate, though operating margin remains negative even before extraordinary items. The minimal investment spending with capex at only 3% of depreciation raises questions about long-term competitive positioning and growth capacity, potentially reflecting strategic uncertainty during the ownership transition.
The revenue contraction of 14.9% YoY represents a structural challenge requiring either market recovery or business model adjustment. Without disclosed guidance or segment detail, visibility into stabilization timing remains limited. The planned delisting eliminates future reporting transparency for public stakeholders, though the tender offer price will reflect acquirer expectations for value creation. The combination of financial strength and operational weakness positions this as a restructuring candidate where the acquirer's strategic vision and execution capability will determine outcomes.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.